Hypertension Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Investigation Report on China's Amlodipine Market, 2018-2022By China Research and Intelligence "...... inese adults has high blood pressure. With the increasing number of hypertensive patients, the market size of antihypertensive drugs is also growing.
Amlodipine is a third-generation calcium antagonist used to treat chronic stable angi......" | 13-Dec-2018 | $2200 | |
Investigation Report on China's Telmisartan Market, 2018-2022By China Research and Intelligence "...... ntagonists (angiotensin receptor blockers, ARBs) are antihypertensive drugs that has been growing rapidly since it emerged in the 1990s. As an important ARB administered orally once a day to treat essential hypertension,
Telmisartan w......" | 13-Dec-2018 | $2200 | |
Investigation Report on China's Metoprolol Market, 2018-2022By China Research and Intelligence "...... he global total. The incidence of hypertension in China rose from 5.1% in 1959 to 37.2% in 2017 by 32.1%. With so many hypertensive patients, China's antihypertensive drug market is growing steadily.
There are various antihypertensive drugs i......" | 14-Nov-2018 | $2200 | |
Global Hypertension Partnering 2012 to 2018By Current Partnering "...... port provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry......" | 01-Oct-2018 | $1995 | |
Investigation Report on China's Irbesartan Market, 2018-2022By China Research and Intelligence "...... thus have replaced the ACEIs in some clinical uses. As a result, the growth of the ACEI market slows down, which leading to a steady increase in the Sartans market. Another growth driver is the new edition of List of Medicines Covered by National Ba......" | 14-Sep-2018 | $2200 | |
Investigation Report on Chinese Valsartan Market, 2018-2022By China Research and Intelligence "...... lower blood pressure. Valsartan tablets are mainly used to treat mild to moderate primary hypertension.
The growing economy has greatly changed the life style and diet of Chinese people and led to the increasing incidence of hypertension in C......" | 05-Jul-2018 | $2200 | |
Investigation Report on China Nifedipine Market, 2010-2019By China Research and Intelligence "...... e, 2.5 million rheumatic heart disease and 5 million congenital heart disease. And one out of five adults suffers from cardiovascular disease which is the leading killer of human health. During the period of 2002-2013, coronary heart disease reported......" | 18-Aug-2015 | $2000 | |
Investigation Report on China Telmisartan Market, 2010-2019By China Research and Intelligence "...... applied in the clinic, 8 kinds of similar drugs have come out for sale and there are also 5 kinds of generic drugs in China. In recent years, telmisartan could be said as the fastest-growing kind of dyazide.
First developed by Boehringer-Ing......" | 18-Jun-2015 | $2000 | |
|